Lecanemabix (Lecavance)
Product detail for Lecanemabix, INN: lecanemabix. Therapeutic area: Neurology. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-027
INN
lecanemabix
Therapeutic Area
Neurology
Status
Active
Owner
Carlos Mendez
Created
2022-04-23
Last Updated
2023-02-26
Markets
3
Presentations
| Form | Strength | Route |
|---|---|---|
| Soft capsule | 10 mg/mL | Intravenous |
| Transdermal patch | 50 mg | Subcutaneous |
| Oral solution | 100 mg | Subcutaneous |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-009 | Raredimab | raredimab | 93875-30-1 | biologic | Active |
| SUB-021 | Lorlatenilib | lorlatenilib | 98101-92-4 | small-molecule | Pending |
Applications (3)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| TGA-2023-0027 | Belgium | NDA | Blocked | Aisha Okonkwo | 2023-11-17 |
| SFDA-2023-0057 | Belgium | Lifecycle Extension | In Progress | Priya Sharma | 2024-01-09 |
| TGA-2023-0087 | Belgium | sMAA | Failed | Priya Sharma | 2024-02-17 |
Markets (3)